In addition, in a soluble form, the plasma level of BTN3A1 was correlated with other immune-evasion-favoring molecules in pancreatic cancer patients according to Bian et al. [48] and was negatively correlated with overall survival. The gene discussed is BTN3A1; the disease is pancreatic neoplasm.